Analysis of Adherence to Fluoxetine Treatment through its Plasma Concentration
DOI:
https://doi.org/10.1590/s2175-97902022e20812Palavras-chave:
Adherence to treatment, Fluoxetine, Norfluoxetine, BMQ, Morisky-Green, Plasma concentrationResumo
Depression plays an important role in non-adherence to medical recommendations. Fluoxetine is a first line of depression treatment. This study aimed to evaluate adherence to drug therapy in fluoxetine users by different methods. A cross-section study was conducted with 53 depressed patients on fluoxetine for at least six months. Drug therapy adherence was assessed by validated questionnaires [Brief Medication Questionnaire (BMQ) and Morisky-Green test (MG)] and by the blood concentration of fluoxetine and its active metabolite norfluoxetine. Blood samples were taken before the daily first dose of fluoxetine. The plasmatic concentration of fluoxetine and norfluoxetine indicated that 58.5% volunteers were within the recommended therapeutic range and thus considered adherent to drug therapy. However, questionnaires indicated a non-adherent majority: 41.5% patients had a high degree of adherence in MG and only 13.2% were adherent to pharmacological treatment in BMQ. Most fluoxetine users showed a plasma concentration of fluoxetine and norfluoxetine within the therapeutic range, despite the low adherence to the drug therapy evaluated by the questionnaires. Thus, we suggest that plasma levels of fluoxetine and norfluoxetine could be used as the main method to check adherence to treatment.
Downloads
Referências
Altamura AC, Moro AR, Percudani, M. Clinical Pharmacokinetics of Fluoxetine. Clin Pharmacokinet. 1994;26(3):201-214.
Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica Diretrizes brasileiras de obesidade 2009/2010 - ABESO - 3.ed. - Itapevi, SP: AC Farmacêutica. 2009.
Ayalon L, Areán P, Alvidrez J. Adherence to antidepressant medication in black and Latino elderly patients. Am J Geriatr Psychiatry. 2005;13(7):572-580.
Barfod T, Sorense H, Nielsen H, Rodkjaer L, Obel N. Simply forgot is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med. 2006;7(5):285-290.
Ben AJ, Neumann CR, Mengue SS. Teste de Morisky-Green e Brief Medication Questionnaire para avaliar adesão a medicamentos. Rev Saúde Pública. 2011;46(2):279-289.
Bertilsson L, Dahl ML, Dalén P, Al-Shurbaji A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol. 2002;53(2):111-122.
Blazquez S, Mas MT, Plana A, Lafuente L. Fluoxetine pharmacogenetics in child and adult populations. Eur Child Adolesc Psychiatry. 2012;21(11):599-610.
Caiaffo V, Oliveira BDR, de Sá FB, Neto JE. Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine. Pharmacol Res Perspect. 2016;4(3):231.
Catterson ML, Preskorn SH. Pharmacokinetics of Selective Serotonin Reuptake Inhibitors: Clinical Relevance. Pharmacol Toxicol. 1996;78(4):203-208.
Da Silva ACC, Raasch JR, Vargas TG, Peteffi GP, Hahn RZ, Antunes MV, et al. Simultaneous determination of fluoxetine and norfluoxetine dried blood spots using high-performance liquid chromatography-tandem mass spectrometry. Clin Biochem. 2018;52:85-93.
Dimatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
Djordjevic S, Kovacevic I, Miljkovic B, Vuksanovic J, Pokrajak M. Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study. Farmaco. 2005;60(4):345-349.
Fritzen JS, Motter FR, Paniz VMV. Regular access and adherence to medications of the specialized componente of pharmaceutical services. Rev Saúde Públ. 2017;51:109.
Guilarducci NV, Alves KB, Santos TR, Baldoni AO, Sanches-Giraud C. Pharmacotherapy of patients in substitutive renal therapy: an adherence approach. Rev Bras Farm Hosp Serv Saude. 2016;7(3):8-12
Harvey AT, Preskorn SH. Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers. J Clin Psychopharmacol. 2001;21(2):161-166.
Hawkshea J, Krousel-Wood MA. Techniques for measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Dis Manag Health Outcomes. 2007;15(2):109-18.
Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update. Pharmacopsychiatry. 2011;44(6):195-235.
Hiemke C, Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000;85(1):1-28.
Hwang ES, Kim GH. Biomarkers of oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology. 2007;229(1-2):1-10.
Kasper MD, Vargas TG, Santos AS, Raach JR, Betti AH, Perassolo MS. Adesão à terapia medicamentosa e qualidade de vida de usuários de uma USF de Novo Hamburgo - RS. Rev Bras Farm Hosp Serv Saude . 2017;8(4):11-17.
Kecskeméti VI, Rusznak Z, Riba P, Pal B, Wagner R, Harasztosi C, et al. Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res Bull. 2005;67(1-2):126-132.
Kuehner C. Why is depression more common among women than among men? Lancet Psychiatry. 2017;4(2):146-158.
Leite SN, Vasconcellos MPC. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Ciênc Saude Coletiva. 2003;8(3):775-82.
Lundmarck J, Bengtsson F, Nordin C, Reis M, Wålinder J. Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients. Acta Psychiatr Scand. 2000;101(5):354-359.
Machado AV. O uso de fluoxetina e fatores associados: estudo populacional. 2018. 70 f., il. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade de Brasília, Brasília, 2018.
Mantovani MF, Mattei AT, Arthur JP, Ulbrich EM, Moreira RC. Utilização do brief medication questionnaire na adesão medicamentosa de hipertensos. Revista de Enfermagem UFPE On Line. 2015;9(1):84-90.
Milstein-Moscati I, Persano S, Castro LLC. Aspectos metodológicos e comportamentais da adesão à terapêutica, pp. 171-179. In Castro LLC (org.). Fundamentos de farmacoepidemiologia. AG Editora, [s.l.]. 2000.
Mineto DR, Campos CAM, Raach JR, Suyenaga ES, Perassolo MS. Medication adherence among users of medicinal plants in South Brazil. Lat Am J Pharm. 2018;37(11):2229-2238.
Mitchell AJ. High medication discontinuation rates in psychiatry: How often is it understandable? J Clin Psychopharmacol . 2006;26(2):109-112.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self - reported measure of medication adherence. Medical Care. 1986;24(1):67-74.
Nevado JJB, Lerena MJV, Salcedo AMC, Nuevo EA. Assay validation for three antidepressants in pharmaceutical formulations: Practical approach using capillary gas chromatography. J Pharm Biomed Anal. 2005;38(1):52-59.
Reis M, Aamo T, Spigset O, Ahlner J. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit. 2009;31(1):42-56.
Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet. 1997;2(60):284-295.
Sima M, Vodicka M, Maresová V, Sálek T, Cabal R, Slanar O. Adherence with perindopril therapy: a pilot study using therapeutic drug monitoring of perindoprilat and an evaluation of the clearance estimation. Int J Clin Pharm. 2017;39(5):1095-1100.
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Coun. 1999;37(2):113-124.
Tavares DMS, Guimaraes MO, Ferreira PCS, Dias FA, Martins NPF, Rodrigues LR. Qualidade de vida e adesão ao tratamento farmacológico entre idosos hipertensos. Rev Bras Enfer. 2016;69(1):134-141.
WHO. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization. (2017). Licence: CC BY-NC-SA 3.0 IGO.
Zeller A, Schroeder K, Peters TJ. Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care. Scand J Prim Health Care. 2007;25(4):202-7.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
